Biodexa Pharmaceuticals Plc Stock price London S.E.
Equities
BDRX
GB00BNGF1L75
Biotechnology & Medical Research
Sales 2023 * | 298K 376K | Sales 2024 * | - | Capitalization | 1.78M 2.25M |
---|---|---|---|---|---|
Net income 2023 * | - | Net income 2024 * | - | EV / Sales 2023 * | 5.98 x |
Net cash position 2023 * | - 0 | Net cash position 2024 * | - 0 | EV / Sales 2024 * | - |
P/E ratio 2023 * |
-
| P/E ratio 2024 * |
-
| Employees | 27 |
Yield 2023 * |
-
| Yield 2024 * |
-
| Free-Float | 57.92% |
Managers | Title | Age | Since |
---|---|---|---|
Stephen Stamp
CEO | Chief Executive Officer | 62 | 19-09-08 |
Vincent Holmes
COO | Chief Operating Officer | - | - |
Dan Palmer
CTO | Chief Tech/Sci/R&D Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Stephen Parker
CHM | Chairman | 65 | 22-06-19 |
Sijmen de Vries
BRD | Director/Board Member | 65 | 14-10-28 |
Stephen Stamp
CEO | Chief Executive Officer | 62 | 19-09-08 |
1st Jan change | Capi. | |
---|---|---|
+2.56% | 108B | |
+10.02% | 104B | |
+7.13% | 23.66B | |
-11.91% | 22.1B | |
-3.29% | 19.71B | |
-35.98% | 18.2B | |
-14.02% | 16.19B | |
+4.61% | 13.72B | |
+35.05% | 12.22B |